The prognostic value of sST2 in connective tissue disease patients with pulmonary hypertension.

Huangshu Ye Qianwen WuNing ZhangJing ShiHaifeng ZhangQiang WangMiaojia ZhangXiaoxuan Sun

Published in: Rheumatology (Oxford, England) (2022)

sST2 ≥ 39.99 ng/ml predicts higher incidence of clinical worsening events in CTD-PH patients. Furthermore, patients with elevated sST2 had significantly worse prognosis among those with high NT-proBNP.

Keyphrases

pulmonary hypertension
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
risk factors
pulmonary arterial hypertension
pulmonary artery
patient reported outcomes
patient reported